Developing new contraceptive methods through chemical screening
CHEMICAL SCREENING AND OPTIMIZATION FACILITY – HIGH THROUGHPUT SCREENING for Contraceptive Targets
This study is working on developing new and safe birth control methods by targeting how eggs and sperm are made, and it aims to create better options for people looking to manage their reproductive health.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Sri International NIH-funded |
| Lab location | 1 site (Menlo Park, United States) |
| Project ID | NIH-11181775 on NIH RePORTER |
What this research studies
This research focuses on creating safe and effective contraceptive agents by disrupting key reproductive processes such as oogenesis and spermatogenesis. The team utilizes advanced techniques like high throughput screening to identify and optimize molecular compounds that can serve as contraceptives. Patients may benefit from innovative contraceptive options that are developed through this research, which aims to enhance reproductive health. The project also involves collaboration with various scientific disciplines to ensure comprehensive development of these agents.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research include individuals seeking new contraceptive options or those interested in reproductive health advancements.
Not a fit: Patients who are not seeking contraception or have no interest in reproductive health may not receive benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new contraceptive methods that are safer and more effective for both men and women.
How similar studies have performed: Previous research in contraceptive development has shown promise with similar high throughput screening approaches, indicating potential for success.
Where this research is happening
Menlo Park, United States
- Sri International — Menlo Park, United States (Active)
Researchers
- Principal investigator: Gong, Leyi — Sri International
- Study coordinator: Gong, Leyi
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.